AR9: (2R,4S)-N-butyl-4-[(2S,5S,7R)-2,7-dimethyl-3,15-dioxo-1,4-diazacyclopentadecan-5-yl]-4-hydroxy-2-methylbutanamide
AR9 is a Ligand Of Interest in 5QCW designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 5QCW_AR9_B_401 | 53% | 74% | 0.193 | 0.956 | 0.4 | 0.59 | - | 1 | 0 | 0 | 100% | 1 |
| 5QCW_AR9_C_401 | 52% | 72% | 0.196 | 0.956 | 0.48 | 0.6 | - | 1 | 0 | 0 | 100% | 1 |
| 5QCW_AR9_A_401 | 46% | 75% | 0.197 | 0.933 | 0.36 | 0.62 | - | 1 | 0 | 0 | 100% | 0.9839 |
| 3DV1_AR9_B_501 | 59% | 42% | 0.165 | 0.949 | 0.73 | 1.48 | - | 6 | 0 | 0 | 100% | 1 |
